Description

Sjogrens Syndrome Market report gives a comprehensive outlook across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report on gives historical, current, and future market sizes (US$ Mn) on the basis of drug class, type, distribution channel and region. This report studies global variable air volume (VAV) systems market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities). Key stakeholders of the report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged. Sjogrens syndrome is an immune disorder which is indicated by two common symptoms dry mouth and dry eyes. Sometimes sjogrens syndromes are associated with other immune disorders like rheumatoid arthritis and lupus. In this condition mucous membrane of mouth and eyes get affected, which results in decreased secretion of tears and saliva. Sjogrens disease can occur at any age, it is more common in women. in October 2015, Allergan introduced synthetic tears REFRESH OPTIVE gel drops to relieve dry eye symptoms. In November 2013, Nicox SA introduced advanced diagnostic panel for detection of sjogrens syndrome in early stages in U.S.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX